Report of Foreign Issuer (6-k)
October 23 2019 - 8:02AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN
PRIVATE ISSUER PURSUANT TO RULE 13a-16
OR 15d-16 UNDER THE SECURITIES EXCHANGE
ACT OF 1934
For the month of October 2019
Commission File Number: 001-36582
Auris Medical Holding Ltd.
(Exact name of registrant as specified
in its charter)
Clarendon House, 2 Church Street
Hamilton HM 11, Bermuda
(Address of principal executive office)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Yes ☐ No ☒
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Yes ☐ No ☒
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
Auris Medical Holding Ltd.
|
|
|
Date: October 23, 2019
|
By:
|
/s/ Thomas Meyer
|
|
|
Name: Thomas Meyer
|
|
|
Title: Chief Executive Officer
|
Exhibit Index
2
Auris Medical (NASDAQ:EARS)
Historical Stock Chart
From Apr 2024 to May 2024
Auris Medical (NASDAQ:EARS)
Historical Stock Chart
From May 2023 to May 2024